Physician profile
Jonathan E Schoen
NPI 1346683356
$7,785.16
in general payments reported to CMS, 2019-2025
14 companies · $4,020 in 2025
The $4,020 reported for 2025 was more than what 88% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $27.41 · 2021: $99.84 · 2022: $76.60 · 2023: $2,756 · 2024: $805 · 2025: $4,020.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,632 · Food and Beverage: $2,165 · Honoraria: $2,000 · Travel and Lodging: $785.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,632.00 |
| Food and Beverage | $2,164.72 |
| Honoraria | $2,000.00 |
| Travel and Lodging | $784.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avita Medical Americas, LLC | $2,844.06 | 2025 | Recell, Permeaderm, Cohealyx |
| Livanova USA, INC. | $2,800.25 | 2021-2023 | Lifesparc |
| Polynovo North America LLC | $1,388.61 | 2023-2025 | Novosorb Btm |
| Aroa Biosurgery Incorporated | $294.91 | 2024 | |
| Innovation Technologies INC | $178.39 | 2024 | Irrisept |
| Urgo Medical North America, LLC | $95.80 | 2024 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Prytime Medical Devices, INC. | $38.03 | 2024-2025 | Preboa-Pro, Er-Reboa Plus |
| Octapharma USA, INC. | $30.77 | 2025 | Fibryga |
| Acera Surgical, INC. | $28.98 | 2025 | Restrata Wound Matrix |
| Avanos Medical | $27.41 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $18.44 | 2023 | |
| Paratek Pharmaceuticals, INC. | $16.82 | 2025 | Nuzyra |
| Kci USA, INC. | $12.11 | 2021 | |
| Potrero Medical, INC. | $10.58 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Schoen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.